Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Stockbridge

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Circulation|May 13, 2024
Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical TrialsJaved Butler, Norman Stockbridge, Milton Packer
Pharmacoepidemiology and Drug Safety|July 5, 2012
Removal from labeling of 60-mg citalopram doseRobert Temple, Thomas Laughren, Norman Stockbridge
European Journal of Heart Failure|September 20, 2017
Past, present, and future of acute heart failure clinical trials-a high-risk population in search of a strategyJaved Butler, Norman Stockbridge, Mihai Gheorghiade
Cellular Signalling|April 24, 2012
How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?Gowraganahalli Jagadeesh, Pitchai Balakumar, Norman Stockbridge
Circulation|November 16, 2020
Benefit-Risk Tradeoffs in Assessment of New Drugs and DevicesSanjay Kaul, Norman Stockbridge, Javed Butler
Nature Reviews. Drug Discovery|February 20, 2016
Evolution of strategies to improve preclinical cardiac safety testingGary Gintant, Philip T Sager, Norman Stockbridge
Journal of Electrocardiology|August 16, 2016
Evolving regulatory paradigm for proarrhythmic risk assessment for new drugsJose Vicente, Norman Stockbridge, David G Strauss
JACC. Basic to Translational Science|September 1, 2018
Resourcing Drug Development Commensurate With its Public Health Importance: The Road AheadMona Fiuzat, Norman Stockbridge, Robert M Califf
Drug Safety|March 13, 2016
Universal Correction for QT/RR HysteresisMarek Malik, Lars Johannesen, Katerina Hnatkova, et al.
Cell Stem Cell|July 8, 2017
The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and DiscoveryGary Gintant, Bernard Fermini, Norman Stockbridge, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Circulation|May 13, 2024
Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical TrialsJaved Butler, Norman Stockbridge, Milton Packer
Pharmacoepidemiology and Drug Safety|July 5, 2012
Removal from labeling of 60-mg citalopram doseRobert Temple, Thomas Laughren, Norman Stockbridge
European Journal of Heart Failure|September 20, 2017
Past, present, and future of acute heart failure clinical trials-a high-risk population in search of a strategyJaved Butler, Norman Stockbridge, Mihai Gheorghiade
Cellular Signalling|April 24, 2012
How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?Gowraganahalli Jagadeesh, Pitchai Balakumar, Norman Stockbridge
Circulation|November 16, 2020
Benefit-Risk Tradeoffs in Assessment of New Drugs and DevicesSanjay Kaul, Norman Stockbridge, Javed Butler
Nature Reviews. Drug Discovery|February 20, 2016
Evolution of strategies to improve preclinical cardiac safety testingGary Gintant, Philip T Sager, Norman Stockbridge
Journal of Electrocardiology|August 16, 2016
Evolving regulatory paradigm for proarrhythmic risk assessment for new drugsJose Vicente, Norman Stockbridge, David G Strauss
JACC. Basic to Translational Science|September 1, 2018
Resourcing Drug Development Commensurate With its Public Health Importance: The Road AheadMona Fiuzat, Norman Stockbridge, Robert M Califf
Drug Safety|March 13, 2016
Universal Correction for QT/RR HysteresisMarek Malik, Lars Johannesen, Katerina Hnatkova, et al.
Cell Stem Cell|July 8, 2017
The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and DiscoveryGary Gintant, Bernard Fermini, Norman Stockbridge, et al.
Pageof 15